Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20948452 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed An Exploratory, Open Label, Single Center Study of [F-18]HX4
Condition: Head and Neck Cancer
Intervention: Drug: 20 mCi dose for a 50 kg individual of [F-18]HX4

Indicates status has not been verified in more than two years